IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
-9.51%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$486M
AUM Growth
+$486M
(+27%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
29.12%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
86
New
15
Increased
40
Reduced
9
Closed
21
Top Buys
| 1 |
Eli Lilly
LLY
|
$23.7M |
| 2 |
Sanofi
SNY
|
$17.5M |
| 3 |
Centene
CNC
|
$16.9M |
| 4 |
McKesson
MCK
|
$13.6M |
| 5 |
DexCom
DXCM
|
$12.4M |
Top Sells
| 1 |
Pfizer
PFE
|
$15.5M |
| 2 |
Globus Medical
GMED
|
$13.3M |
| 3 |
Acadia Healthcare
ACHC
|
$9.83M |
| 4 |
AMED
Amedisys
AMED
|
$6.89M |
| 5 |
Cigna
CI
|
$5.99M |
Sector Composition
| 1 | Healthcare | 97.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Xenon Pharmaceuticals
XENE
$2.99B
| $2.96M | 0.61% |
+97,281
| New | +$2.96M |
|
52
Heron Therapeutics
HRTX
$204M
| $2.79M | 0.57% |
1,000,000
| – | – |
|
53
Akero Therapeutics
AKRO
$3.65B
| $2.72M | 0.56% |
288,058
+88,058
| +44% | +$832K |
|
54
Arcturus Therapeutics
ARCT
$467M
| $2.46M | 0.51% |
156,553
+31,553
| +25% | +$497K |
|
|
NSTG
55
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.39M | 0.49% |
+188,500
| New | +$2.39M |
|
56
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $2.28M | 0.47% |
234,830
+63,830
| +37% | +$619K |
|
57
Lifestance Health
LFST
$2.14B
| $2.09M | 0.43% |
375,728
+225,728
| +150% | +$1.26M |
|
58
SI-BONE Inc
SIBN
$700M
| $2.08M | 0.43% |
157,317
-77,683
| -33% | -$1.03M |
|
59
Insmed
INSM
$30.3B
| $2.06M | 0.42% |
104,369
-45,631
| -30% | -$900K |
|
60
Atara Biotherapeutics
ATRA
$88.7M
| $1.63M | 0.33% |
208,738
-91,262
| -30% | -$711K |
|
|
FMTX
61
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $896K | 0.18% |
130,051
+40,051
| +45% | +$276K |
|
|
CINC
62
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $787K | 0.16% |
+41,748
| New | +$787K |
|
63
Lexicon Pharmaceuticals
LXRX
$392M
| $558K | 0.11% |
+300,000
| New | +$558K |
|
64
Dianthus Therapeutics
DNTH
$781M
| $394K | 0.08% |
328,269
+127,269
| +63% | +$153K |
|
|
LBPH
65
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $177K | 0.04% |
57,335
+9,735
| +20% | +$30.1K |
|
|
SRRA
66
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – |
-30,000
| Closed | -$962K |
|
|
ICPT
67
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-125,000
| Closed | -$2.03M |
|
|
CMRX
68
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-119,000
| Closed | -$545K |
|
69
Teleflex
TFX
$5.57B
| – | – |
-8,000
| Closed | -$2.84M |
|
70
Regenxbio
RGNX
$498M
| – | – |
-90,000
| Closed | -$2.99M |
|
71
PMV Pharmaceuticals
PMVP
$82.1M
| – | – |
-50,000
| Closed | -$1.04M |
|
|
72
Pfizer
PFE
$141B
| – | – |
-300,000
| Closed | -$15.5M |
|
73
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-35,000
| Closed | -$3.28M |
|
74
Keros Therapeutics
KROS
$640M
| – | – |
-81,000
| Closed | -$4.41M |
|
75
Intuitive Surgical
ISRG
$158B
| – | – |
-16,000
| Closed | -$4.83M |
|